JRVR:NASDAQJames River Group Holdings, Inc. Analysis
Data as of 2026-04-12 - not real-time
$6.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
James River Group (JRVR) trades at a trailing P/E of 7.5, well below the industry average of 17.1, indicating a significant valuation discount. The price‑to‑book ratio of 0.53 and a DCF‑derived upside of ~24% further support an undervalued assessment. Revenue has surged 32% year‑over‑year, driven by strong growth in its excess and surplus lines business. The combined ratio improved to 96.6% from 117.6% a year earlier, signaling better underwriting profitability. Net income rebounded to $47.4 million, reversing a prior loss and delivering a 15% return on tangible equity. The dividend yield of 0.65% is backed by a 4.8% payout ratio, suggesting the dividend is sustainable.
Technically, the stock sits at $6.20, below both the 20‑day (6.26) and 50‑day (6.55) moving averages, indicating short‑term pressure. However, the RSI of 45 and a bullish MACD histogram hint at a potential bottom‑fade. Volume trends are decreasing, and 30‑day volatility is high at 42%, contributing to a moderate liquidity risk. The beta of 0.54 points to lower market sensitivity, tempering overall risk. Given the valuation gap, improving fundamentals, and modest technical support at $5.92, the stock appears poised for a medium‑term rebound. Consequently, we recommend a buy stance for medium and long horizons, with a hold approach in the near term pending confirmation of price stability.
Technically, the stock sits at $6.20, below both the 20‑day (6.26) and 50‑day (6.55) moving averages, indicating short‑term pressure. However, the RSI of 45 and a bullish MACD histogram hint at a potential bottom‑fade. Volume trends are decreasing, and 30‑day volatility is high at 42%, contributing to a moderate liquidity risk. The beta of 0.54 points to lower market sensitivity, tempering overall risk. Given the valuation gap, improving fundamentals, and modest technical support at $5.92, the stock appears poised for a medium‑term rebound. Consequently, we recommend a buy stance for medium and long horizons, with a hold approach in the near term pending confirmation of price stability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near support
- decreasing volume
- high volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- undervalued valuation
- strong revenue growth
- improved underwriting profitability
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- sustainable dividend
- low payout ratio
- stable cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth32.40%
Profit Margin6.90%
P/E Ratio7.5
ROE7.88%
ROA0.94%
Debt/Equity50.19
P/B Ratio0.5
Op. Cash Flow$-18786000
Free Cash Flow$1.0B
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI45.1
Support$5.92
Resistance$6.64
MA 20$6.26
MA 50$6.55
MA 200$5.97
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
Fair Value$826.10
Target Price$7.67
Upside/Downside23.66%
GradeUndervalued
TypeBlend
Dividend Yield0.65%
Risk Assessment
Beta0.54
Volatility42.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.